Pneumocystis pneumonia in a patient with non-small cell lung cancer (NSCLC) treated with pemetrexed containing regimenVELCHETI, Vamsidhar; GOVINDAN, Ramaswamy.Lung cancer. 2007, Vol 57, Num 2, pp 240-242, issn 0169-5002, 3 p.Article

Clinical trials of antiangiogenic therapy in non-small cell lung cancer : focus on bevacizumab and ZD6474MORGENSZTERN, Daniel; GOVINDAN, Ramaswamy.Expert review of anticancer therapy. 2006, Vol 6, Num 4, pp 545-551, issn 1473-7140, 7 p.Article

TP53 Mutations and Lung Cancer: Not All Mutations Are Created EqualGOVINDAN, Ramaswamy; WEBER, Jason.Clinical cancer research (Print). 2014, Vol 20, Num 17, pp 4419-4421, issn 1078-0432, 3 p.Article

Lung cancer in never smokers : A reviewSUBRAMANIAN, Janakiraman; GOVINDAN, Ramaswamy.Journal of clinical oncology. 2007, Vol 25, Num 5, pp 561-570, issn 0732-183X, 10 p.Article

Benign pleural nodules in a patient with esophageal cancerWAN TECK LIM; GOVINDAN, Ramaswamy.Journal of clinical oncology. 2006, Vol 24, Num 3, issn 0732-183X, p. 525Article

Response to bortezomib (velcade) in a case of advanced bronchiolo-alveolar carcinoma (BAC) A case reportSUBRAMANIAN, Janakiraman; PILLOT, Giancarlo; NARRA, Vamsidhar et al.Lung cancer. 2006, Vol 51, Num 2, pp 257-259, issn 0169-5002, 3 p.Article

Treatment approaches in patients with advanced non-small cell lung cancer and poor performance statusGOVINDAN, Ramaswamy; GARFIELD, David H.Seminars in oncology. 2004, Vol 31, Num 6, pp 27-31, issn 0093-7754, 5 p., SUP11Article

Cetuximab in advanced non-small cell lung cancerGOVINDAN, Ramaswamy.Clinical cancer research. 2004, Vol 10, Num 12, pp 4241s-4244s, issn 1078-0432, 2Conference Paper

A Phase I Trial of Sunitinib and Rapamycin in Patients with Advanced Non-Small Cell Lung CancerWAQAR, Saiama N; GOPALAN, Priya K; WILLIAMS, Kristina et al.Chemotherapy (Basel). 2013, Vol 59, Num 1, pp 8-13, issn 0009-3157, 6 p.Article

The epidemiology of bronchioloalveolar carcinoma over the past two decades: analysis of the SEER databaseREAD, William L; PAGE, Nathan C; TIERNEY, Ryan M et al.Lung cancer. 2004, Vol 45, Num 2, pp 137-142, issn 0169-5002, 6 p.Article

Time to Activate Lung Cancer Clinical Trials and Patient Enrollment: A Representative Comparison Study Between Two Academic Centers Across the AtlanticWANG-GILLAM, Andrea; WILLIAMS, Kristina; NOVELLO, Silvia et al.Journal of clinical oncology. 2010, Vol 28, Num 24, pp 3803-3807, issn 0732-183X, 5 p.Article

Definitive chemoradiation for the treatment of locally advanced non-small-cell lung cancerBLACKSTOCK, A. William; GOVINDAN, Ramaswamy.Journal of clinical oncology. 2007, Vol 25, Num 26, pp 4146-4152, issn 0732-183X, 7 p.Article

Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3YONGJUN YIN; BETSUYAKU, Tomoko; GARBOW, Joel R et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 18, pp 5730-5741, issn 0008-5472, 12 p.Article

Primary Analysis of the Phase II Component of a Phase I/II Dose Intensification Study Using Three-Dimensional Conformal Radiation Therapy and Concurrent Chemotherapy for Patients With Inoperable Non―Small-Cell Lung Cancer: RTOG 0117BRADLEY, Jeffrey D; BAE, Kyounghwa; GRAHAM, Mary V et al.Journal of clinical oncology. 2010, Vol 28, Num 14, pp 2475-2480, issn 0732-183X, 6 p.Article

Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non-Small-Cell Lung Cancer : TheHoosier Oncology Group and U.S. OncologyHANNA, Nasser; NEUBAUER, Marcus; RICHARDS, Donald et al.Journal of clinical oncology. 2008, Vol 26, Num 35, pp 5755-5760, issn 0732-183X, 6 p.Article

A phase 1 escalating single-dose and weekly fixed-dose study of cetuximab : Pharmacokinetic and pharmacodynamic rationale for dosingFRACASSO, Paula M; BURRIS, Howard; CHODKIEWICZ, Catherine et al.Clinical cancer research. 2007, Vol 13, Num 3, pp 986-993, issn 1078-0432, 8 p.Article

EGFR-T790M is a rare lung cancer susceptibility allele with enhanced kinase activityVIKIS, Haris; SATO, Mitsuo; PINNEY, Susan M et al.Cancer research (Baltimore). 2007, Vol 67, Num 10, pp 4665-4670, issn 0008-5472, 6 p.Article

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: An early measure of responseVOLLMER, Robin T; GOVINDAN, Ramaswamy; GRAZIANO, Stephen L et al.Clinical cancer research. 2003, Vol 9, Num 5, pp 1728-1733, issn 1078-0432, 6 p.Article

Incorporating bortezomib into the treatment of lung cancer. DiscussionDAVIES, Angela M; LARA, Primo N; MACK, Philip C et al.Clinical cancer research. 2007, Vol 13, Num 15, issn 1078-0432, 4647s-4651s, 2Conference Paper

A phase I trial of docetaxel and vinorelbine in patients with advanced non-small cell lung cancerGOVINDAN, Ramaswamy; LIM, Wan-Teck; ARQUETTE, Matthew A et al.Oncology reports. 2006, Vol 15, Num 1, pp 123-127, issn 1021-335X, 5 p.Article

Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapiesGOVINDAN, Ramaswamy; CROWLEY, John; SCHWARTZBERG, Lee et al.Journal of clinical oncology. 2006, Vol 24, Num 30, pp 4848-4854, issn 0732-183X, 7 p.Article

Phase II Trial of Cetuximab in Patients With Previously Treated Non-Small-Cell Lung CancerHANNA, Nasser; LILENBAUM, Rogerio; ANSARI, Rafat et al.Journal of clinical oncology. 2006, Vol 24, Num 33, pp 5253-5258, issn 0732-183X, 6 p.Article

Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University ExperienceKOMMAREDDY, Aruna; COPLIN, Margaret A; FENG GAO et al.Lung cancer. 2004, Vol 45, Num 2, pp 221-225, issn 0169-5002, 5 p.Article

Randomized Phase II Study of Pemetrexed, Carboplatin, and Thoracic Radiation With or Without Cetuximab in Patients With Locally Advanced Unresectable Non-Small-Cell Lung Cancer: Cancer and Leukemia Group B Trial 30407GOVINDAN, Ramaswamy; BOGART, Jeffrey; STINCHCOMBE, Thomas et al.Journal of clinical oncology. 2011, Vol 29, Num 23, pp 3120-3125, issn 0732-183X, 6 p.Article

Page / 3